Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Ciscom Corp. Strengthens Its Board of Directors with Addition of Two Experienced Industry Leaders (click to learn more) Silver North Options GDR Silver Project, Silvertip-Midway District, Yukon (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News GRI Bio Inc GRI

Healthcare Biotechnology
GRI Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering, developing, and commercializing therapies that target serious diseases associated with dysregulated immune responses leading to inflammatory, fibrotic, and autoimmune disorders. Its therapies are designed to target the activity of Natural Killer T (NKT) cells, which are key regulators earlier in... see more

Recent & Breaking News (NDAQ:GRI)

Vallon Pharmaceuticals Announces Stockholder Approval of Merger with GRI Bio, Inc. and Reverse Stock Split

GlobeNewswire April 20, 2023

Vallon Pharmaceuticals Adjourns Special Meeting of Stockholders Until April 20, 2023

GlobeNewswire April 12, 2023

Vallon Pharmaceuticals Provides an Update on Proxy Voting for the Proposed Merger with GRI Bio and Urges Stockholders of Record as of March 6, 2023 to Vote by April 11, 2023, at 11:59 PM ET

GlobeNewswire April 4, 2023

Vallon Pharmaceuticals Reports Fiscal Year 2022 Financial Results

GlobeNewswire February 24, 2023

SHAREHOLDER ALERT: Weiss Law Reminds SESN, MLVF, VLON, and SHBI Shareholders About Its Ongoing Investigations

PR Newswire February 22, 2023

SHAREHOLDER ALERT: Weiss Law Reminds SESN, MLVF, VLON, and APEN Shareholders About Its Ongoing Investigations

PR Newswire February 15, 2023

SHAREHOLDER ALERT: Weiss Law Reminds SESN, MLVF, VLON, and APEN Shareholders About Its Ongoing Investigations

PR Newswire February 8, 2023

SHAREHOLDER ALERT: Weiss Law Reminds SESN, MLVF, VLON, and APEN Shareholders About Its Ongoing Investigations

PR Newswire February 1, 2023

SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - APEN, VLON, TIG, PSBP

PR Newswire January 27, 2023

SHAREHOLDER ALERT: Weiss Law Reminds MLVF, VLON, APEN, and HZN Shareholders About Its Ongoing Investigations

PR Newswire January 25, 2023

SHAREHOLDER ALERT: Weiss Law Reminds DCP, SESN, MLVF, and VLON Shareholders About Its Ongoing Investigations

PR Newswire January 17, 2023

Vallon Pharmaceuticals and GRI Bio to Present at the Virtual Investor 2023 Companies to Watch Event

GlobeNewswire January 11, 2023

SHAREHOLDER ALERT: Weiss Law Reminds SESN, MLVF, VLON, and APEN Shareholders About Its Ongoing Investigations

PR Newswire January 6, 2023

SHAREHOLDER ALERT: Weiss Law Reminds WEBR, SESN, MLVF, and VLON Shareholders About Its Ongoing Investigations

PR Newswire December 29, 2022

SHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Vallon Pharmaceuticals, Inc. - VLON

Newsfile December 27, 2022

SHAREHOLDER ALERT: Weiss Law Reminds SESN, MLVF, VLON, and MTCR Shareholders About Its Ongoing Investigations

PR Newswire December 20, 2022

SHAREHOLDER ALERT: Weiss Law Investigates Vallon Pharmaceuticals, Inc.

PR Newswire December 15, 2022

Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators

GlobeNewswire December 13, 2022

Vallon Pharmaceuticals Reports Third Quarter 2022 Financial Results

GlobeNewswire November 3, 2022

Vallon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

GlobeNewswire July 28, 2022